The global women’s health diagnostics market was valued at USD 24.8 billion in 2021 and it is anticipated to grow up to USD 49.0 billion by 2031, at a CAGR of 7.0% during the forecast period.
Global Women’s Health Diagnostics Market report from Global Insight Services is the single authoritative source of intelligence on Women’s Health Diagnostics Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters’ and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.
Screening, testing or diagnosing, and monitoring of various women’s health disorders such as ovarian cancer, breast cancer, menopause, pregnancy and cervical cancer are examples of women’s health diagnostic methods. For the diagnosis of women’s health-related diseases, various types of tests are available including Breast cancer testing, cervical cancer testing, prenatal genetic screening & carrier testing, pregnancy & ovulation testing, and ovarian cancer testing are all part of the diagnostic process.
To Remain ‘Ahead’ Of Your Competitors, Request for A Sample – https://www.globalinsightservices.com/request-sample/GIS10385/
Market Trends and Drivers
Rising prevalence of chronic and infectious diseases in females is poised to boost the market expansion. Changes in lifestyle and growing consumption of unhealthy food will upsurge the risk of disease. Moreover, lack of awareness regarding sanitation and genital health coupled with unavailability of well-developed healthcare facilities in developing economies will fuel the market growth during the forecast period. Additionally, increasing healthcare expenditure, availability of newer and advanced diagnostic systems and growth in awareness about malignant tumors, are anticipated to propel the industry growth in near future. Furthermore, growing number of product developments and strategic collaboration among the diagnostic device market players and their entry in developing countries provide numerous opportunities for market progression.
Market Segments
By Type
- Diagnostic Devices
- Diagnostic Tests
By Application
- Breast Cancer
- Infectious Disease Testing
- Osteoporosis Testing
- Pregnancy and Fertility Testing
By End-use
- Hospitals and Clinics
- Diagnostic and Imaging Centers
Request For Customization – https://www.globalinsightservices.com/request-customization/GIS10385/
Key Players
- Abbott (U.S.)
- BD (U.S.)
- Cardinal Health, Inc. (U.S.)
- F.Hoffmann-La Roche Ltd. (Switzerland)
- General Electric Company (U.S.)
- Hologic, Inc. (U.S.)
- Koninklijke Philips N.V. (Netherland)
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1–833–761–1700